Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2025-12-16 @ 9:21 PM
Study NCT ID:
NCT06394518
Status:
None
Last Update Posted:
2024-05-01 00:00:00
First Post:
2024-04-27 00:00:00
Brief Title:
Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants
Sponsor:
TenNor Therapeutics Inc
Organization:
TenNor Therapeutics Inc.
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2023-02-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-02-24
Completion Date Type:
ACTUAL
First Submit Date:
2024-04-27 00:00:00
First Submit QC Date:
April 27 2024
Study First Post Date:
2024-05-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-27 00:00:00
Last Update Post Date:
2024-05-01 00:00:00
Last Update Post Date Type:
ACTUAL